| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, July 2008, p. 2644-2646, Vol. 52, No. 7
0066-4804/08/$08.00+0 doi:10.1128/AAC.01618-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Iwona Wozniok,1,
Christian Blockhaus,1
Oliver Kurzai,2
Holger Hebart,3
Hermann Einsele,1 and
Juergen Loeffler1*
Medizinische Klinik & Poliklinik II,1 Institut für Hygiene und Mikrobiologie, Universität Würzburg, 97070 Würzburg,2 Staufer-Klinik Schwäbisch Gmünd, Innere Medizin, 73557 Mutlangen, Germany3
Received 18 December 2007/ Returned for modification 15 January 2008/ Accepted 11 April 2008
Mycophenolic acid (MPA) is used clinically to prevent graft rejection but may increase the risk of fungal infection. We observed that MPA enhanced the Aspergillus fumigatus-induced oxidative burst of polymorphonuclear neutrophils, but without a corresponding increase in fungal killing. Furthermore, MPA inhibited the proinflammatory cytokine response and maturation of dendritic cells.
Published ahead of print on 21 April 2008.
M.M. and I.W. contributed equally to this work.
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |